Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,146 | 626 | 97.6% |
| Consulting Fee | $150.00 | 1 | 1.4% |
| Education | $100.50 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $2,786 | 110 | $0 (2024) |
| ABBVIE INC. | $1,795 | 218 | $0 (2024) |
| EMD Serono, Inc. | $1,428 | 48 | $0 (2024) |
| PFIZER INC. | $510.88 | 59 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $355.15 | 33 | $0 (2022) |
| GENZYME CORPORATION | $345.11 | 15 | $0 (2024) |
| TG Therapeutics, Inc. | $317.12 | 9 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $289.59 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $264.18 | 16 | $0 (2024) |
| Genentech USA, Inc. | $262.18 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,815 | 178 | Biogen, Inc. ($565.79) |
| 2023 | $2,778 | 158 | Biogen, Inc. ($848.02) |
| 2022 | $2,726 | 174 | Biogen, Inc. ($676.13) |
| 2021 | $2,077 | 119 | Biogen, Inc. ($696.54) |
All Payment Transactions
629 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Neuroscience | ||||||
| 12/20/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.43 | General |
| 12/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.45 | General |
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: PAIN | ||||||
| 12/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.88 | General |
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| 12/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $145.18 | General |
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.20 | General |
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $59.28 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $58.82 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Neurology | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: PAIN | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $64.45 | General |
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 43 | 91 | $25,480 | $8,904 |
| 2022 | 1 | 42 | 95 | $26,600 | $8,404 |
| 2021 | 4 | 123 | 264 | $24,071 | $8,247 |
| 2020 | 5 | 157 | 419 | $39,182 | $11,817 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 91 | $25,480 | $8,904 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 95 | $26,600 | $8,404 | 31.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 62 | $17,360 | $6,308 | 36.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 19 | $3,971 | $1,180 | 29.7% |
| 85610 | Blood test, clotting time | Office | 2021 | 33 | 92 | $920.00 | $394.68 | 42.9% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 34 | 91 | $1,820 | $363.47 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 88 | $18,392 | $5,382 | 29.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 70 | $9,940 | $2,754 | 27.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 28 | $7,840 | $2,480 | 31.6% |
| 85610 | Blood test, clotting time | Office | 2020 | 45 | 165 | $1,650 | $702.27 | 42.6% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 26 | 68 | $1,360 | $497.85 | 36.6% |
About Erin Feitz
Erin Feitz is a Family healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801078308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erin Feitz has received a total of $10,396 in payments from pharmaceutical and medical device companies, with $2,815 received in 2024. These payments were reported across 629 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,146).
As a Medicare-enrolled provider, Feitz has provided services to 365 Medicare beneficiaries, totaling 869 services with total Medicare billing of $37,371. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Registered Nurse, Family
- Location Overland Park, KS
- Active Since 11/27/2007
- Last Updated 05/12/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1801078308
Products in Payments
- TYSABRI (Biological) $2,202
- UBRELVY (Drug) $1,011
- NURTEC ODT (Drug) $908.58
- QULIPTA (Drug) $573.58
- ACTHAR (Biological) $289.59
- BRIUMVI (Drug) $279.56
- KESIMPTA (Drug) $264.18
- BOTOX (Biological) $263.43
- ZEPOSIA (Drug) $238.37
- UPLIZNA (Drug) $204.05
- AUBAGIO (Drug) $200.11
- EMGALITY (Drug) $150.57
- OCREVUS (Biological) $140.40
- VYEPTI (Biological) $130.97
- Ocrevus (Biological) $125.52
- MAVENCLAD (Drug) $119.06
- PURIFIED CORTROPHIN GEL (Drug) $89.43
- Aimovig (Biological) $81.57
- VUMERITY (Drug) $73.90
- Mavenclad (Drug) $73.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Overland Park
Mrs. Jennifer Chester, Fnp, FNP
Family — Payments: $326,831
Kathryn Timm, Arnp-C, ARNP-C
Family — Payments: $10,867
Ms. Lauren Barber, Np-C, NP-C
Family — Payments: $8,407
Nicole Walton, Aprn, APRN
Family — Payments: $7,325
Gretchen Poland, Arnp-C, ARNP-C
Family — Payments: $5,016
Nisa Gregson, Aprn, APRN
Family — Payments: $4,377